Optellum

Oxford, United Kingdom

Optellum develops an imaging biomarker for smart lung cancer detection.

$14.0M raised

Sep 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Optellum raised?

Optellum has raised $14.0M in total funding. The most recent round was Series A. The last funding was announced in September 2022.

Who are Optellum's investors?

Optellum's investors include IQ Capital, Black Opal Ventures, Luminous Ventures, Intuitive Ventures, Mercia Fund Managers.

Where is Optellum headquartered?

Optellum is headquartered in Oxford, United Kingdom.

What does Optellum do?

Optellum develops an imaging biomarker for smart lung cancer detection.

What stage is Optellum at?

Optellum is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 27, 2022.

MLA

"Optellum — Funding & Investors." VCBacked, September 27, 2022, https://www.vcbacked.co/company/optellum. Accessed July 2, 2026.

APA

VCBacked. (2022). Optellum — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/optellum

Wikipedia (cite web)

{{cite web |title=Optellum — Funding & Investors |url=https://www.vcbacked.co/company/optellum |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 27, 2022.